Adult Formulation Hep B Vaccine (Engerix) Shortage
Monday, June 26 2017
SA Health is aware of supply constraints of adult formulation hepatitis B vaccine due to a precautionary halt in the manufacturing process of the GlaxoSmithKline (GSK) Engerix-B® vaccine. Production has returned to normal, however it will take time to rebuild capacity. Seqirus vaccine, H-B-Vax II® – adult formulation, and hepatitis A and B combination vaccines can still be sourced.
The Engerix-B® and H-B-Vax II® vaccines are manufactured by different processes. Switching mid-course between monovalent hepatitis B vaccine brands is not routinely recommended, however, under the current circumstances it is acceptable. Switching mid-course between monovalent and combination vaccines is not recommended.
For more details please click the media link.